Jane Street Group, LLC Syros Pharmaceuticals, Inc. Transaction History

Jane Street Group, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	BUY	$0.69 - $1.21 $2,263 - $3,970	3,281 Added 23.77%	17,085 $16,000
Q1 2022 May 17, 2022	SELL	$1.02 - $3.8 $13,054 - $48,636	-12,799 Reduced 48.11%	13,804 $16,000
Q4 2021 Feb 15, 2022	SELL	$3.26 - $4.66 $169,542 - $242,352	-52,007 Reduced 66.16%	26,603 $87,000
Q3 2021 Nov 16, 2021	BUY	$4.08 - $5.66 $104,346 - $144,754	25,575 Added 48.22%	78,610 $352,000
Q2 2021 Aug 16, 2021	BUY	$5.01 - $7.48 $76,337 - $113,972	15,237 Added 40.31%	53,035 $289,000
Q1 2021 May 18, 2021	SELL	$7.19 - $14.95 $123,869 - $257,558	-17,228 Reduced 31.31%	37,798 $283,000
Q4 2020 Feb 17, 2021	BUY	$6.66 - $14.66 $366,473 - $806,681	55,026 New	55,026 $597,000

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $43.1M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.